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“Wnt signal transduction” cascade consists of various proteins (14)
 A family of cysteine-rich secreted glycoproteins.
 19 mammalian Wnt proteins have been identified to fall into 12 conserved 
Wnt subfamilies.
 Binding to 10 different Frizzled receptor and other co-receptors.
 Acylation (on  cysteine residues 77 & 209) and N-glycosylation (on Asn103 
and Asn414 residues) are Wnt Post-translational modifications that are 
accomplished by acyltransferase porcupine (located in ER).
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“Wnt signal transduction play roles in embryonic & adult stages in human 
and animals (8, 10 , 11, 17): 
 Evolution
 Cell proliferation, growth & differentiation
 Cell survival, stem cell renewal & organ formation.
 Wnt pathway components are “directional growth factor” (induce cell 
proliferation, and both primary formation & maintenance of tissue 
exact shape (8).
Wnt signal transduction Roles
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 Signal transduction 3 pathways:
 1.Canonical pathway
 2.Non-canonical planar cell polarity pathway
 3.Non-canonical Wnt/calcium pathway (8).
 Wnt pathway component mutation may be cause to some pathological
conditions such as cancer (10). 
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Cohen & et al 2008(22)
9The Wnt Secretion Machinery
Clevers & Nusse& 2012(4)
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Nusse& Clevers 2017(2)
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Introduction
 “Wnt” is a cysteine-rich 40kD protein, that is attached to a palmitoleic acid 
(an acyl group) before its secretion from cells.
 Wnt is acylated when it is inside the cell. 
 This acyle group facilitates Wnt passing through the cell membrane and 
binding to its receptors (10)
 Notum enzyme (a deacylase) can remove acyl group and deactivate the Wnt. 
Deacylated Wnt can not attach to its receptor (10, 16).
Model of Wnt Secretion
http://wires.wiley.com/WileyCDA/WiresArticle/wisId-WSBM1422.html(21) 
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Small-Molecule to activate or inhibite Wnt signaling
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Selected Wnt pathway inhibitors & their use in mouse tumor models
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Wnt is one of the “cancer-related signaling pathways” which its 
abnormal expression was observed in many cancers such as 
(11,8)
 Lung
 Breast
 Ovarian
 hematopoietic malignancies
 Especially hepatocellular carcinoma & (colorectal(18,19)) cancer.
Wnt & Related Diseases 
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 Wnt1 is a sign of tumor metastasis(11).
 Wnt3a over-expression relates with MMP-9 level in colorectal cancer 
(11).
&  by decrease in -catenin acetylation & increase the cytosolic β-
catenin can increase the MCF-7 cells proliferation (11,12).
 Wnt signaling can play roles in cancer stem cell (CSCs) activities 
drug resistance & cancer metastasis in various cancers (colon, breast 
and cutaneous) (12).
Wnt & Related Diseases 
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Wnt & Related Diseases 
Curtin &  Lorenzi 2017 (12)
Canonical Wnt signaling and dysregulation in cancer.
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 More than 90% of colorectal cancers occurred because of at least one 
mutation in Wnt signaling pathway genes.
 Wnt3 can increase stem cells number in normal intestinal epithelial 
tissue.
 In colorectal cancer, APC or CTNNB1 mutation  Wnt signaling 
activation intestinal epithelial stem cell transformation into 
adenoma carcinoma (via some other genes alterations such as 
SMAD4, KRAS, and TP53 genes).
 Other Wnt signaling pathway genes which altered in colorectal cancer 
are: FZD10, T-cell factors-3 and -4 (TCF3/4) (TCF7L1/2), axis inhibitor 2 
(AXIN2) (13).
Wnt & Related Diseases 
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Masuda etal.2015 (13).
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 They synthesized a small molecule, referred to as HI-B1with inhibitory effect 
against β-catenin/TCF4 interaction in colon cancer cells.
 HI-B1 : causes apoptosis of cancer cells in which the survival is dependent on 
β-catenin.
Synthesis of 4-(5-Fluoro-1H-Benzo[d]Imidazol-2-yl)-N, Ndimethylaniline (HI-
B1):
 To a solution of 4-(Dimethylamino) benzaldehyde in ethanol, Sodium 
dithionite in water was added. 
 The resulting mixture was stirred at room temperature for 20 min 
 then 4-Fluoro-1,2-phenylenediamine  was added.
 after14 h The solution was diluted with water.
 The obtained brown precipitate was filtered and purified from ethanol to give 
2.5 g of 4-(5-fluoro-1H-benzo[d]imidazol-2- yl)-N, N-dimethylaniline .
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 Luciferase Assay,  MTS Assay,  Flow Cytometry for Analysis of Apoptosis, 7-Day 
Proliferation Assay, Quantitative PCR (qRT-PCR), Protein Purification 
,Immunohistochemistry.
 β-catenin is a direct target protein of HI-B1. HI-B1 disrupts the interaction 
between β-catenin and TCF4 in vitro and ex vivo.
 HI-B1 inhibits the growth of tumors with a high expression level of β-catenin, 
but was not effective against tumors with a low level of β-catenin. 
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